Merck inks deal on tetanus, diphtheria vaccine
WHITEHOUSE STATION, N.J. - April 21, 2010 -- Merck & Co. has entered a deal with nonprofit vaccine maker MassBiologics to distribute its vaccine against tetanus and diphtheria, in the big drugmaker's latest move to remain dominant in vaccines.
Merck says it will start distributing the Td vaccine in June, throughout the U.S. except for Massachusetts. The vaccine will still be distributed in that state by MassBiologics, a 116-year-old vaccine developer now run by the University of Massachusetts Medical School.
Tetanus and diphtheria are both bacterial illnesses whose incidence has greatly been reduced by vaccines. Tetanus, also called lockjaw, kills about one in five infected patients. Diphtheria, which is spread by coughing and sneezing, can cause temporary paralysis and abnormal heart rhythms.
- Dump truck hits ATV pulling sled, boy killed
- 3 frigid days, another weekend storm
- WATCH: Action News Online
- 2013 Troop Greetings
- Woman killed in Germantown was Villanova prof.
- On video: Robber dives thru window, attacks clerk
- Limo driver charged in wreck that killed newlyweds
- Camden man accused of robbing 5 banks in 1 month 9 min ago
- Pa. girl, 18, survives bear attack
- New video shows deadly Asiana jet crash 23 min ago
- Women sentenced in murder of Danny DeGennaro 32 min ago
- Mega Millions jackpot climbs; $1M ticket sold in NJ
- Fake deaf interpreter crashes Mandela memorial
- Bedbug fighter recalled over fire hazard 2 min ago